| Prev Close | 160.65 |
| Day Low/High | 159.11 / 161.41 |
| 52 Wk Low/High | 109.16 / 161.95 |
Johnson & Johnson (JNJ)
160.30
NYSE
| Exchange | NYSE |
| Shares Outstanding | 2632.54B |
| Market Cap | 422.92B |
| P/E Ratio | 27.75 |
| Div & Yield | N.A. (N.A) |
Geron Shares Rise on Fast Track Designation -- Biotech Movers
The FDA granted fast track designation to imetelstat as a potential treatment for adults with with transfusion-dependent anemia.
Cramer: How We Got Into This Rotation
Everything's set up to compound it, and that's just what's happening.
Eli Lilly Had a Good Quarter but Investors Don't Want Health Stocks: Jim Cramer
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer said Eli Lilly LLY had a good quarter but the stock is getting hit by a rotation, as opposed to its specific performance.
My Takeaways and Observations
There's something happening here What it is ain't exactly clear There's a man with a gun over there Telling me I got to beware -- Buffalo Springfield, For What Its Worth Few longs meet my standards and I now believe risk exceeds reward (S&P kind) by...
Cramer: How to Find the Open Receiver in a Pullback
You've got to run the stock checkdown.
Cramer: If Monday Was Black, Tuesday Was Even Darker
It was as if the world had ended and it didn't matter what you owned, it was going down.
How Jim Cramer Skillfully Navigated the 1987 Black Monday Crash -- Video
TheStreet's Jim Cramer wasn't affected by the 1987 Black Monday crash -- his hedge fund was in cash!
Cramer: What's Tax Reform Got to Do With It?
Treasury secretary says it's baked into the market, but is anyone really counting on it?
UnitedHealth and Insurance Agreement Lead Dow, S&P 500 to Records
The Dow ended the day at all-time highs for its second session in a row, though missed out on ending above that 23,000 mark it hit earlier.
Cramer: Stocks May Be Cheaper Than We Think
There's a case to be made for underpricing, even in this market.
Should You Listen to a Talking Head?
"Everyone is putting money in the market, so you might as well follow." -- CNBC talking head In the aggregate, the markets were uneventful -- with another remarkably narrow range in the S&P Index. But there were some major movers.  On the upside,...
UnitedHealth and J&J Drive Dow to 23,000 but Rest of Market Wavers
Positive earnings from UnitedHealth Group and Johnson & Johnson sweep the Dow Jones Industrial Average to top 23,000 and hit a new all-time high.
Cramer: Getting Out the Bad News Gives a Post-Earnings Boost
When management gets ahead of bad news, it allows a stock to prosper when the company reports earnings.
Cramer: This Market's Like a Seafood Restaurant, Always a Catch of the Day
Today that catch was McDonald's, tomorrow it will probably be something different.
My Takeaways and Observations
"While options can give market participants the protection they are intended to provide, they can also increase the degree of a counter move, once it gets going, as those who wrote the protection scramble to unwind their own exposure." -- Kass Diary...
Cramer: These Research Upgrades Are Actually Having an Impact
Colgate, First Data and Snap, among other stocks, could rise on these analyst actions, and here's why.
Johnson & Johnson Shares May Need a Band-Aid Before They Can Rally
I continue to have my doubts about JNJ rallying to new highs.
Is Johnson & Johnson Sitting Out the Rally?
When a stock isn't doing anything while the market is up, you have to ask questions.
Cramer: Sellers May Be Ready to Give You Some Bargains
The third day of a trading period is typically the day we see sellers, after two up days.
Here's When to Go Long Johnson & Johnson
We remain positive on JNJ.
Positive Signs in Drug Distribution
Blockbuster drugs still need companies to deliver them.
Cramer: 5 Stocks That Turned Negatives Into Positives
This is the kind of action you get when you have a real bull market.
Cramer: Is There a Human Element to This Rally?
It could be all machine-to-machine and not much more than that.
The Best Companies for Women
Working Mother and the National Association of Female Executives surveyed companies and found the best ones that do right by women. Find out who you should be working for.
Cramer: Goldman's Downgrade Of J&J Is 'Questionable'
Johnson & Johnson had a very good acquisition
Johnson & Johnson Is Getting Ready for Another Upside Breakout
A cover shorts signal was triggered, and an outright go long signal could follow soon.
Cramer: Got the Apple-FANG Blues? Look for a Rotation
There's one going on now.
Johnson & Johnson, 3M and 8 Other Winners From the Ridiculously Weaker Dollar
U.S. companies that have significant sales in Europe are about to reap the benefits of a weak greenback.
Cramer: There Should Be More Takeovers Where These Came From
Buying's good for the acquirers, which should give other companies ideas.
